Jeffrey L Brown

A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models

Mohammad Tabrizi, Steve Emery, Corinne Reimer, 2010, Molecular Cancer Therapeutics.

Preclinical anti-tumor activity of XR5944 in combination with carboplatin or doxorubicin in non-small-cell lung carcinoma

P. Charlton, Prakash Mistry, P. Mistry, 2005, Anti-cancer drugs.